Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3413-3420

  Betea, D ^a   Bradwell, A R ^b   Harvey, T C ^c   Mead, G P ^b   Schmidt Gayk, H ^d   Ghaye, B ^a   Daly, A F ^a   Beckers, A ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MANOR HOSPITAL   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; FREUND ADJUVANT; HORMONE ANTIBODY; PARATHYROID HORMONE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SIZE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LABORATORY TEST; LUNG METASTASIS; PARATHYROID CARCINOMA; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ANIMALS; ANTIBODY FORMATION; CALCIUM; CARCINOMA; CATTLE; FEMALE; HUMANS; IMMUNOTHERAPY; LUNG NEOPLASMS; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PEPTIDE FRAGMENTS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

BOVINAE; POMACANTHUS MACULOSUS;

EID: 3242700230     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031911     Document Type: Article

References (25)

1. Shane E 2001 Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493
2. Kebebew E 2001 Parathyroid carcinoma. Curr Treat Options Oncol 2:347-354
3. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, et al 1995 Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-950
4. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657-663
5. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729
6. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath 3rd H, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, The BT, Larsson C, Hobbs MR 2002 HKPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680
7. Kebebew E, Arici C, Duh QY, Clark OH 2001 Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 136:878-885
8. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ 1998 Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83:1083-1088
9. Silverberg SJ, Faiman C, Bilezikian JP, Shoback DM, Rubin MR, McCary LC, Olson KA, Turner SA, Peacock M 2003 The effects of cinacalcet HCl (AMG 073) on serum calcium levels in patients with parathyroid carcinoma or recurrent primary HPT after PTX. J Bone Miner Res 18(Suppl 1):S171 (Abstract)
10. Rubin M, Sliney J, McCary LC, Silverberg SJ, Bilezikian JP 2003 Effective management of severe hypercalcemia with the calcimimetic cinacalcet HCl in patients with parathyroid carcinoma. J Bone Miner Res 18(Suppl 1):S392 (Abstract)
11. Bradwell AR, Harvey TC 1999 Control of hypercalcaemia of parathyroid carcinoma by immunisation. Lancet 353:370-373
12. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA 2002 Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169:1984-1992
13. Mead GP, Harvey T, Epstein M, Beckers A, Bradwell AR, Hypercalcaemia of parathyroid carcinoma controlled by immunotherapy. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 93 (Abstract OR21-3)
14. Mosca PJ, Clay TM, Kim Lyerly H, Morse MA 2003 Current status of dendritic cell immunotherapy of malignancies. Int Rev Immunol 22:255-281
15. Schott M, Feldkamp J, Schattenburg D, Krueger T, Dozenrath C, Seissler J, Scherbaum WA 2000 Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol 142:300-306
16. Schott M, Feldkamp J, Lettmann M, Simon D, Scherbaum WA, Seissler J 2001 Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma. Clin Endocrinol (Oxf) 55:271-277
17. Bachleitner-Hofmann T, Stift A, Friedl J, Pfragner R, Radelbauer K, Dubsky P, Schuller G, Benko T, Niederle B, Brostjan C, Jakesz R, Gnant M 2002 Mar stimulation of autologous antitumor T cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells. J Clin Endocrinol Metab 87:1098-1104
18. Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S 2003 Tumors as elusive targets of T cell-based active immunotherapy. Trends Immunol 24:335-342
19. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213
20. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD 2002 Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991-998
21. i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation. A mechanism for localizing systemic responses in bone. J Biol Chem 276:9565-9571
22. McCauley LK, Koh AJ, Beecher CA, Rosol TJ 1997 Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells. Endocrinology 138:5427-5433
23. Kotzmann H, Koller M, Abela C, Clodi M, Riedl M, Graninger W, Niederle B, Luger A 1998 Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism. Eur J Clin Invest 28:353-358
24. Tzanno-Martins C, Futata E, Jorgetti V, Duarte AJ 2000 Restoration of impaired T cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 84:224-227
25. Ozdemir F, Sezer S, Ozdemir B, Arat Z, Yakupoglu U, Turan M, Haberal M 2002 Influence of parathyroid hormone level on renal allograft outcome, and correlation with histopathological findings. Tissue Antigens 60:552